In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Look Back at 2006: The Pipeline Challenge

Executive Summary

Our review of top stories of 2006 touches on a variety of subjects, but the majority drive to one über-theme: the pipeline challenge. Products suddenly disappeared into the generic abyss, with nothing new to take their places. Compounds likely to succeed didn't. The price of in-licensable products soared. Even relatively good news for pipelines largely reflected the absence of further bad news: the safety squabbles did not result in higher hurdles to product approvals.
Advertisement

Related Content

Biopharma: Reviewing 2007 to Forecast 2008
SPAC Merger Opens Door for Alsius
Clinical Update: AIDS Research Marches On
AHA Wrap-Up: Studies Emphasize Improved Outcomes, Cost Effectiveness
Industry Perspective - The Medtech Industry: A Look Back at 2006
Share the Wealth? No Thanks
Vertex/J&J: Pushing Big Pharma's Deal Flexibility to the Limit
The Large Molecule Future
FibroGen Wins Big Upfront, Keeps US Rights to Oral Anemia Drug
No Dilution Necessary: The Promise of Project Financing

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002843

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel